×
For best experience we recommend to activate Javascript in your browser.
Recombinant RABV G (Mazorelvimab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA, WB
Host: CHO Cells
Monoclonal
unconjugated
Recombinant Antibody
Product Details anti-RABV G (Mazorelvimab Biosimilar) Antibody
(hide)
Target
RABV G (Mazorelvimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
CHO Cells
Clonality
Monoclonal
Application
ELISA, Western Blotting (WB)
Purpose
Mazorelvimab Biosimilar - Anti-G Glycoprotein mAb
Characteristics
Antibody Type: IgG1-kappa
Grade
Research Grade
Isotype
IgG1 kappa
Application Details
(hide)
Restrictions
For Research Use only
Handling
(hide)
Buffer
PBS buffer pH 7.5
Storage
-80 °C
Storage Comment
store at -80°C
Target Details for RABV G (Mazorelvimab Biosimilar)
(hide)
Target
RABV G (Mazorelvimab Biosimilar)
Target Type
Biosimilar
Background
CTB 012, CTB-012, CTB012, SYN023 Mazorelvimab (SYN023) is a combination of CTB011 and CTB012 humanized monoclonal antibodies cocktail against rabies virus (RABV). Mezagitamab binds to non-overlapping epitopes on RABV glycoprotein (G). Mezagitamab has potential application in the prevention of rabies.
Recently viewed
(hide)